Page 45 - ARNM-2-3
P. 45

Advances in Radiotherapy
            & Nuclear Medicine                                                        Molecular imaging of lung cancer



               Cells. 2020;9(8):1755.                             Rev Biochem Mol Biol. 2013;48(3):222-272.
               doi: 10.3390/cells9081755                          doi: 10.3109/10409238.2013.770819
            120. Sun Y, Liu Z, Huang L, Shang Y. MiR-144-3p inhibits the   126. Qiao X, Gu Y, Yu J, et al. The combination of CD147 and
               proliferation, migration and invasion of lung adenocargen   MMP-9 serum levels is identified as novel chemotherapy
               cancer cells by targeting COL11A1.  J  Chemother.   response markers of advanced non-small-cell lung cancer.
               2021;33(6):409-419.                                Dis Markers. 2020;2020:8085053.
               doi: 10.1080/1120009x.2021.1906031                 doi: 10.1155/2020/8085053
            121. Chen M, Zhang J, Zeng J, Yu Y, Gu C. Circular circRANGAP1   127. Han L, Chen Y, Huang N,  et al. Cancer-educated
               contributes to non-small cell lung cancer  progression by   neutrophils promote lung cancer progression via PARP-
               increasing COL11A1 expression through sponging miR-  1-ALOX5-mediated MMP-9 expression.  Cancer Biol Med.
               653-5p. Biochem Genet. 2023;61(6):2580-2598.       2024;21(2):175-92.
               doi: 10.1007/s10528-023-10393-x                    doi: 10.20892/j.issn.2095-3941.2023.0248
            122.  Qiao H, Feng Y, Tang H. COL6A6 inhibits the proliferation   128. Wang CY, Chen CL, Tseng YL, et al. Annexin A2 silencing
               and metastasis of non-small cell lung cancer through the JAK   induces G2 arrest of non-small cell lung cancer cells through
               signalling pathway. Transl Cancer Res. 2021;10(10):4514-4522.  p53-dependent and -independent mechanisms. J Biol Chem.
               doi: 10.21037/tcr-21-2002                          2012;287(39):32512-32524.
            123. Ma Y, Qiu M, Guo H, et al. Comprehensive analysis of the      doi: 10.1074/jbc.M112.351957
               immune and prognostic implication of COL6A6 in lung   129. Ling X, Qi C, Cao K, et al. METTL3-mediated deficiency of
               adenocarcinoma. Front Oncol. 2021;11:633420.       lncRNA HAR1A drives non-small cell lung cancer growth
               doi: 10.3389/fonc.2021.633420                      and metastasis by promoting ANXA2 stabilization.  Cell
                                                                  Death Discov. 2024;10(1):203.
            124. Gong L, Wu D, Zou J, et al. Prognostic impact of serum and
               tissue MMP-9 in non-small cell lung cancer: A systematic      doi: 10.1038/s41420-024-01965-w
               review and meta-analysis. Oncotarget. 2016;7(14):18458-68.  130. Wang Y, Wang Y, Liu W,  et al. TIM-4 orchestrates
               doi: 10.18632/oncotarget.7607                      mitochondrial homeostasis to promote lung cancer
                                                                  progression via ANXA2/PI3K/AKT/OPA1 axis. Cell Death
            125. Vandooren J, Van den Steen PE, Opdenakker G.
               Biochemistry and molecular biology of gelatinase B or   Dis. 2023;14(2):141.
               matrix metalloproteinase-9 (MMP-9): The next decade. Crit      doi: 10.1038/s41419-023-05678-3




































            Volume 2 Issue 3 (2024)                         13                             doi: 10.36922/arnm.4173
   40   41   42   43   44   45   46   47   48   49   50